SETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Xinyi,Zhou

第一单位： Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.;Department of Urology, Xiangya Hospital, Central South University, Hunan, Changsha, China.

作者： Xinyi,Zhou ^[1] ; Yohei,Sekino ^[2] ; Hong-Tao,Li ^[3] ; Guanghou,Fu ^[4] ; Zhi,Yang ^[5] ; Shuqing,Zhao ^[5] ; Hemant,Gujar ^[3] ; Xiongbing,Zu ^[6] ; Daniel J,Weisenberger ^[7] ; Inderbir S,Gill ^[3] ; Varsha,Tulpule ^[8] ; Anishka,D'souza ^[8] ; David I,Quinn ^[8] ; Bo,Han ^[5] ; Gangning,Liang ^[3]

作者单位： Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.;Department of Urology, Xiangya Hospital, Central South University, Hunan, Changsha, China. ^[1] Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.;Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. ^[2] Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California. ^[3] Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.;Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. ^[4] Department of Surgery, Keck School of Medicine of USC, Los Angeles, California; Department of Surgery and Biomedical Engineering, Keck School of Medicine USC, Los Angeles, California. ^[5] Department of Urology, Xiangya Hospital, Central South University, Hunan, Changsha, China. ^[6] Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. ^[7] Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. ^[8]